The development of optimized therapy strategies against malignant tumors is critically dependent on the assessment of tissue-based biomarkers in routine diagnostic tissue samples. We investigated a novel, fully automated, and xylene-free method for RNA isolation and biomarker determination using formalin-fixed paraffin-embedded (FFPE) tissue. The aim was to show that this approach is feasible and gives results that are comparable to the current gold standards. Expression of the breast cancer biomarkers ESR1, PGR, and HER2 was measured in a total of 501 FFPE tissue samples from 167 breast carcinomas, which had been stored for up to 21 years. Total RNA was extracted from tissue sections and biomarker expression was measured by kinetic RT-PCR (RT-kPCR). The results of the new method were compared with immunohistochemistry as the current gold standard. RNA was successfully isolated from all samples, with a mean yield of 1.4 mg/sample and fragment lengths of at least 150 bp in 99% of samples. RT-kPCR analysis of ESR1, PGR, and HER2 was possible in all samples. Comparing RT-kPCR results with standard IHC, we found a good concordance for ESR1 (agreement: 98.4%), PGR (84.4%), and HER2 (89.8%). We observed a low section-tosection variability of kPCR results for all 3 biomarkers (root of mean squared errors: 0.2 to 0.5 Ct values). The new approach is a reliable high-throughput instrument for standardized testing of biomarkers in clinical routine and for research studies on archived FFPE material up to 21 years old. For the assessment of ESR1, PGR, and HER2 the results are comparable to the current gold-standard.
T he development of optimized therapy strategies against malignant tumors depends on a multidisciplinary approach, and the decision on the best therapeutic option is often based on biomarker assessment in formalin-fixed paraffin-embedded (FFPE) tumor tissue. For example, the state-of-the-art management of breast cancer includes the investigation of the predictive markers estrogen receptor (ESR1) and progesterone receptor (PGR), and HER2. These predictive markers are used to guide antiestrogenic therapy or anti-HER2-directed targeted therapy. [1] [2] [3] For evaluation of predictive markers in FFPE tissue, immunohistochemistry (IHC) is currently the diagnostic gold standard. 4 IHC gives robust signals for many biomarkers, which could be correlated with morphology. However, the degree of expression of the marker can only be described in a semiquantitative way. Several studies have evaluated the interlaboratory variation in assessment of hormone receptor stainings. 5, 6 Despite international efforts to standardize the cutoffs and the method, 7-9 a complete standardization of IHC for assessment of estrogen and progesterone receptors is difficult owing to the inherent semiquantitative nature of the technology. In clinical practice, substantial problems in biomarker diagnostics in breast cancer have been reported. 10, 11 Therefore it is necessary to develop additional quantitative methods for biomarker assessment that are complementary to the current immunohistochemical techniques.
Owing to the current focus on targeted therapies, several additional predictive biomarkers are under development.
Many of the upcoming new biomarkers can be measured only on the mRNA level. For example, the RNA-based OncotypeDX 21-gene assay has recently been included in American treatment guidelines to identify patients with ESR1-positive, tamoxifen-treated breast cancer who do not need adjuvant chemotherapy. 12, 13 In addition, large collections of archival FFPE tissue samples exist in pathology institutions. In contrast to the usually limited collections of frozen tissue, these FFPE tissue samples could facilitate validation of biomarkers in adequately powered research studies.
Therefore, it is critical to implement quantitative, reliable, and standardized high-throughput methods for an investigation of mRNA expression in routine and archived FFPE tissue. However, the use of FFPE tissue for mRNA-based gene expression analyses have several limitations because formalin fixation leads to RNA fragmentation and cross-linkage with proteins and requires a manual deparaffinization step with harmful reagents. 14, 15 Recently, we presented a novel standardized and fully automated method with an extraction-integrated xylene and ethanol-free deparaffinization step for fast isolation of total RNA from FFPE tissue sections. 16 In this study, we evaluated the storage timedependent performance and reproducibility of the new automated RNA isolation method using 501 samples from 167 FFPE breast tumors. Furthermore, we quantified the mRNA expression levels of the breast cancer biomarkers ESR1, PGR, and HER2 with kinetic reverse transcription polymerase chain reaction (RT-kPCR) and compared the results with state-of-the-art IHC.
MATERIALS AND METHODS

Sample Preparation
One hundred sixty-seven tissue samples of invasive breast cancer diagnosed at the Charite´Hospital, Berlin, Germany between 1987 and 2008 were included in this study; the use of tumor samples was approved by the institutional review board of the Charite´University hospital. Tissue samples were fixed in neutrally buffered formalin. The surgical specimen were placed into formalin during the surgical procedure or-in some cases-after frozen section evaluation. Therefore, the time to fixation was usually between 5 and 20 minutes. The FFPE tissues were stored at room temperature. General handling procedures and storage conditions of the tissue samples have been similar in the study period. Table 1 gives a summarized overview about patient characteristics. The percentage of tumor tissue was evaluated on hematoxylin and eosin (H&E) stained sections.
From each paraffin block, 5 consecutive 10-mm sections were cut and placed into individual Sarstedt tubes (P/N 72.692.005, Sarstedt, Nu¨mbrecht, Germany). Sections 1, 3, and 5 were used for RNA extraction. An adjacent section was used for IHC.
Immunhistochemical Staining
Immunohistochemical staining was carried out using the DISCOVERY XT autostainer (Ventana, Tucson, AZ), using a rabbit monoclonal antibody to ESR (clone SP1, Neomarkers, 1:50), a monoclonal mouse anti-human PGR antibody (clone PgR 636, Dako, 1:50) and a rabbit anti-human HER2 HercepTest polyclonal antibody (Dako, 1:300). Furthermore, we used the DAB MAP Kit (Ventana, Tucson, AZ) with the DISCOVERY Universal Secondary Antibody (Ventana, Tucson, AZ). For all staining runs, positive and negative controls were used. Immunohistochemical staining was evaluated by 2 pathologists (C.D. and B.M.) who were blinded to the results of RT-kPCR. For assessment of hormone receptor status, the percentage of positive tumor cells was evaluated. 17 The assessment of the HER2 reactivity was carried out according to the current ASCO/CAP guidelines. 18 IHC slides with more than 10% positive staining cells were considered to be ESR1 and PGR positive, and slides with a DAKO score of 3 were considered to be HER2 positive. 
RNA Extraction
The fully automated isolation method of total RNA from FFPE tissue was done using iron oxide beads coated with a nanolayer of silica in combination with a liquid handling robot as described earlier. 16 In brief, FFPE sections were lysed with heat, proteinase K, and detergent. After lysis, residual tissue debris was removed from the lysis fluid with 40-mL silica-coated iron oxide beads. Following 15 minutes incubation at 651C beads with surface-bound tissue debris were separated on a magnet and lysates were transferred to a 2-mL deep-well plate (96 wells). During magnetization, the melted paraffin separates and forms a ring around the tube wall through hydrophobic interactions. After deparaffinization, total RNA and DNA were bound to 40 mL of a fresh volume of beads with shaking at room temperature under chaotropic conditions. Then, beads were magnetically separated and supernatants were discarded. Next, surface-bound nucleic acids were washed 3 times followed by magnetization, aspiration and disposal of supernatants, respectively. Afterward, nucleic acids were eluted by incubation of the beads with 100-mL elution buffer for 10 minutes at 701C with shaking. Finally, beads were separated and the remaining supernatant was incubated with 12-mL DNase I Mix to remove copurified DNA. After incubation for 30 minutes at 371C, DNA-free total RNA solution was obtained. The method took a total of 4 hours and 20 minutes to extract 48 samples including hands-on time of 30 minutes. For each run, 2 positive controls [10-mm sections of the MaxArray Breast Receptor Control Cell Block (Invitrogen, Karlsruhe, Germany)] and 1 negative control (empty tube) were included.
Assessment of RNA Concentration and Quality
Concentration of RNA was assessed using the QUANT-iT RIBOGREEN assay (Invitrogen, Karlsruhe, Germany) according to the manufacturer's instruction. For assessment of mRNA yield, RNA expression of RPL37A was measured by RT-kPCR as described below.
For determination of the mRNA fragment length of the housekeeping gene glucose-6-phosphatdehydrogenase (G6PDH) qualitative RT-PCR analyses were done with 1 sense primer and 5 different antisense primers resulting in amplicons of 67, 151, 242, 379, or 453 bp as described by Liu et al. 19 
Gene Expression Analysis Using RT-kPCR
Expression of ESR1, PGR, HER2 and of the normalization genes RPL37A and CALM2 was assessed by one-step kinetic reverse transcription PCR using the SuperScript III PLATINUM One-Step Quantitative RT-PCR System with ROX (Invitrogen, Karlsruhe, Germany) according to manufacturer's instructions in an ABI PRISM 7900HT (Applied Biosystems, Darmstadt, Germany) with 30 minutes at 501C, 2 minutes at 951C followed by 40 cycles of 15 seconds at 951C and 30 seconds at 601C. Relative expression levels of genes of interest (GOI) were calculated as DCt value [DCt = 20-(Ct GOI -Ct RPL37A or CALM2 )]. DCt values positively correlate with relative gene expression. The optimal cut-off points for RPL37A-normalized data were defined for classification of ESR1, PGR, and HER2 status based on the column scatter plots. Positivity for ESR1 mRNA was defined as a DCt of more than 14.5, negativity for ESR1 was determined as a DCt less than 13.5 Those few samples that were between 13.5 and 14.5 were designated as equivocal for ESR1 mRNA expression. For PGR mRNA the upper and lower cutoff were 12 and 11, respectively, the samples between both cutoffs were regarded as equivocal. For HER2 mRNA the upper and lower cutoff were 19 and 18, respectively, the samples between both cutoffs were regarded as equivocal.
DNA contamination in RNA preparations was assessed using a PAEP gene-specific kinetic PCR without reverse transcription as described above. Samples were considered to be substantially free of DNA when Ct values above 38 were detected. PCR assays were carried out in triplicates. The sequences of the primers and probes were as follows: ESR1: forward: 5 0 -GCCAAATT GTGTTTGATGGATTAA-3 0 , reverse: 5 0 -GACAAAA CCGAGTCACATCAGTAATAG-3 0 , probe: 5 0 -ATGC CCTTTTGCCGATGCA-3 0 (amplicon length: 73 bp); PGR: forward: 5 0 -AGCTCATCAAGGCAATTGGT TT-3 0 , reverse: 5 0 -ACAAGATCATGCAAGTTATCAA GAAGTT-3 0 , probe: 5 0 -TTGATAGAAACGCTGTGAG CTCGA-3 0 (100 bp); HER2: forward: 5 0 -CCAGCCTTC GACAACCTCTATT-3 0 , reverse: 5 0 -TGCCGTAGGT GTCCCTTTG-3 0 , probe: 5 0 -ACCAGGACCCACCA GAGCGGG-3 0 (87 bp); RPL37A: forward: 5 0 -TGTGG TTCCTGCATGAAGACA-3 0 , reverse: 5 0 -GTGACAGC GGAAGTGGTATTGTAC-3 0 , probe: 5 0 -TGGCTGG CGGTGCCTGGA-3 0 (65 bp); CALM2: forward: 5 0 -GA GCGAGCTGAGTGGTTGTG-3 0 , reverse: 5 0 -AGTCA GTTGGTCAGCCATGCT-3 0 , probe: 5 0 -TCGCGTCTC GGAAACCGGTAGC-3 0 (72 bp); PAEP: forward: 5 0 -C ACAGAATGGACGCCATGAC-3 0 , reverse: 5 0 -AAACC AGAGAGGCCACCCTAA-3 0 , probe: 5 0 -AAGCCCTC AGCCCTGCTCTCCATC-3 0 (72 bp).
Statistical Evaluation
The softwares PRISM 4 (GraphPad Software, Inc., La Jolla, CA) and MatLab (The MathWorks Inc., Version R2007b, Ismaning, Germany) were used. For comparison of multiple groups, the one-way ANOVA test was used. P values smaller than 0.05 were considered to be statistically significant. For correlation analyses, the Spearman correlation coefficient was calculated. Sectionto-section and assay-to-assay variabilities were calculated as root of mean squared error.
Agreement between the RT-kPCR and IHC methods uncorrected for chance was calculated as the number of samples which agree divided by the total number of samples. Positive agreement was calculated as the number of samples positive in both methods divided by the number of samples positive in IHC. Negative agreement was determined accordingly. Agreement corrected for chance was determined by estimating Cohen's k coefficient.
RESULTS
RNA Isolation From FFPE Tissue-RNA Yield and Fragment Size
The concentration of total RNA was assessed in the isolate from 1 section of each of the 167 tumors. The mean yield was 1.36 mg per section (range: 0.10 to 7.83 mg). We used the mRNA expression level of the housekeeping gene RPL37A as surrogate marker for the yield of mRNA obtained from each FFPE tissue section. Amplifiable mRNA of RPL37A could be detected in all 501 samples with Ct values below 28 in 498 (99%) of RNA preparations. In principle, RPL37A Ct values below 31 indicate sufficient RNA for quantification of biomarker expression. As assessed by DNA-specific kPCR for the PAEP gene in none of the 501 samples residual DNA was detected (data not shown).
To examine the fragment length of mRNA isolated from the FFPE tissue sections, we did RT-PCR analyses for the housekeeping gene G6PDH using primers that can amplify different fragment sizes. In all 167 samples, a 67-bp amplicon and in 166 of 167 (99%) samples, a 151-bp amplicon could be detected ( Fig. 1 ). However, in only 3 of 167 samples (1.8%) a 242-bp fragment was successfully amplified, whereas in none of the samples a larger amplicon than 242 bp was observed. This shows that in more than 99% of samples mRNA fragments had a length of at least 150 bases.
Isolation of RNA From Samples With Different Storage Times
The storage time of the FFPE samples used in our study ranged between 2 months and 21 years. Amplifiable mRNA of RPL37A could be detected in all samples, regardless of the different storage times, indicating an efficient isolation of mRNA even from 21 years old FFPE tissue ( Fig. 2A) . We found an age-dependent significant decrease of amplifiable mRNA during the first 10 years of storage of the samples. Similarly, yield of total RNA significantly decreased from a mean of 2.9-mg per section to 1.4 mg over the first 10 years of storage ( Fig. 2B ). No further decrease was observed in samples older than 10 years. There was no evidence for ongoing RNA fragmentation during long-term storage.
Comparison of Quantitative RT-PCR of ESR1, and PGR With IHC as the Current Gold-standard
In all 501 samples, the mRNA expression levels of ESR1, PGR, HER2, and the housekeeping genes RPL37A and CALM2 could be determined using RT-kPCR. The broad dynamic range gave a good basis for quantitative marker assessment. For ESR1 and PGR the RPL37A-normalized gene expression measured by RT-kPCR had a dynamic range of about 12 DCt values that corresponds to 3.5 log (base 10). Relative gene expression values of ESR1 showed a bimodal distribution whereas PGR was unimodally distributed (Figs. 3A, B) .
Comparing the results from RT-kPCR with IHC a high concordance was found for both genes (Figs. 3A, B ; Table 2 ). In the first analysis, all samples that were Quantitative Determination of Estrogen Receptor equivocal on the mRNA level (3.7% of samples for ESR1 assessment, 6.7% of samples for PGR) were not included in the comparison. In this analysis, an overall agreement of 98% between RT-PCR and IHC was found for ESR1. Positive and negative agreements were also 98%. For PGR, overall agreement of both methods was 88%, positive agreement was 99%. However, several samples with 10% or less positive staining cells were judged as positive in RT-kPCR resulting in a moderate negative agreement of 78%. As second, more stringent analysis, all samples were evaluated and the samples that were equivocal on the mRNA level were included in the positive group (Table  2) . Even in this analysis, almost perfect overall, positive and negative agreements of 98% were found for ESR1. For PGR, overall agreement of both methods was 83%, positive agreement was 99%. However, several samples with 10% or less positive staining cells were judged as positive in RT-kPCR resulting in a moderate negative agreement of 70%.
Comparison of Quantitative RT-PCR of Her2 With Immunohistochemistry
HER2 expression varied over a range of about 9
DCt values with a bimodal distribution of the relative gene expression values (Fig. 3C ). In the first analysis, all samples that were equivocal on the HER2 mRNA level were excluded (2.4% of samples). In this first analysis, we observed an overall agreement of 91% between both methods comparing DAKO score 0 to 2+ with score 3+ (Fig. 3C, Table 2 ). Negative agreement was excellent (95%), whereas positive agreement was only 64%. In particular, the concordance was limited in samples with weak (score 2) or strong expression (score 3).
We conducted a second, more stringent analysis in which all cases were evaluated and the equivocal cases were included in the positive group (Table 2) . Here we observed an overall agreement of 90% between both methods comparing DAKO score 0 to 2+ with score 3+ Negative agreement was excellent (94%), whereas positive agreement was only 67%. In particular, the concordance was limited in samples with weak (score 2) or strong expression (score 3).
Section-to-section and Assay-to-assay Variability of Biomarker Analysis
To assess the variability of the RT-kPCR results in different RNA eluates from the same tumor, we compared the results of 3 different tissue sections of each tumor. We found a highly significant correlation of the RPL37A Ct values between 2 sections of the 167 tumors (Spearman R = 0.93, 95% CI 0.90-0.95, P<0.0001). The standard deviation of the RPL37A Ct values in 3 consecutive sections was in mean 0.36. For RPL37A-normalized levels of ESR1, PGR, and HER2, excellent correlations of gene expression between 2 tissue sections were observed (Figs. 4A-C). Variations above one DCt value were only observed in the low copy expression range in which RT-kPCR precision is the limiting factor. Comparing 3 sections, the root of mean squared errors of ESR1, PGR, and HER2 DCt values in 3 sections of a tumor were 0.23, 0.54, and 0.34, respectively (Fig. 4D ). An age dependence of sectionto-section variability was not observed. Finally, we examined the concordance of the RT-kPCR-based classification of the ESR1, PGR, and HER2 status as positive or negative in RNA isolated from 3 different tissue sections. The section-to-section agreement of RT-kPCR receptor status was excellent. For ESR1 in 99%, for PGR in 98%, and for HER2 in 99% of tumors an agreement of the classifications was found in all 3 sections including equivocal samples and even 100% without inclusion of samples that were regarded equivocal on the mRNA level (Table 2) .
Moreover, assay-to-assay variability was assessed by a second, independent measurement of the normalized expression values of ESR1, PGR, and HER2. Assay-toassay variability (PCR variability) of the expression of Results are presented without samples that were regarded as equivocal (eq) on the mRNA level (left columns, range of Ct values designated as equivocal is given for each biomarker) and with the equivocal cases in the positive group (right columns, cutoff Ct value is indicated). these genes was low and comparable to the section-tosection variability (Fig. 4D) .
The results after normalization with the housekeeping gene CALM2 were similar to the results with RPL37A normalization (data not shown).
DISCUSSION
In this study, we evaluated the feasibility of quantitative biomarker assessment in FFPE tissue using a new fully automated system for RNA isolation linked to a kinetic RT-PCR. Using a cohort of 501 samples, we compared the results with the current gold standards. The main result of our study was that the determination of biomarkers was possible in all 501 samples and showed a good to excellent correlation with the current diagnostic standard approaches. Samples that were stored for up to 21 years were suitable for the analysis, some older samples showed a slightly lower output of RNA, which could be easily compensated by normalization procedures. Our study did not show a correlation between the age of the samples and the amplifiable fragment sizes determined with RT-PCR of the G6PDH mRNA. Therefore, we interpret the reduced yield in older samples with reduced release of nucleic acids during lysis from surrounding cross-linked cellular components and proteins, but not with increased degradation of mRNA. 14, 15 In general, there have been no significant changes in handling procedures and storage conditions in our institute within the last 21 years. So in our opinion, this cannot be the reason for the reduced yield in older samples. Results might be different owing to different fixation and storage conditions in other institutions, which might require additional testing. Overall, the method allowed successful isolation of total RNA with a mean yield of 1.36-mg per section. Assuming about 2 ng input RNA per one-step RT-kPCR reaction each sample would allow the quantitative analysis of at least hundred biomarker genes. We observed a low biologic section-to-section variability which did not exceed the PCR variability itself, suggesting that the variability is contributed by the PCR rather than by the RNA isolation technique or the heterogeneity of the tumor.
Different manual protocols for RNA extraction from FFPE tissue have been developed. [20] [21] [22] [23] Most of the protocols use similar principles such as deparaffinization, cell disruption, and release of RNA from cross-linked proteins by proteinase K. RNA is subsequently extracted using silica columns or beads and chaotropic salts. Especially the deparaffinization step employs harmful reagents and needs ethanol/xylene treatment steps in combination with centrifugations impeding a complete automation. Furthermore, the complexity of FFPE samples from different tissue types compromises the standardization of RNA extraction protocols. Thus, the use of the existing methods in a routine laboratory for high-throughput analyses is comparably difficult and labor-intensive.
Compared with other methods for RNA extraction, one major new feature of the presented method is the extraction-integrated deparaffinization step by means of an efficient hydrophobic absorption of paraffin to the inner polypropylene tube wall of the tube. This replaces the harmful and labor-intensive ethanol/xylene steps and is one precondition for complete automation. Another important and innovative feature of the method is the introduction of a bead-based negative selection step to bind and eliminate any undigested tissue (debris) in the absence of chaotropic salts before RNA extraction. The separation of tissue debris is another key for complete automation; otherwise such material would interfere with accurate liquid handling resulting in clogging of pipette tips. In addition, this negative selection step is the prerequisite to define a standardized lysis time (here 1 h) and hence makes the method applicable to the complexity of FFPE samples with variable tissue input and cell/matrix composition. The complete automation results in a processing time of 4 hours and 20 minutes for 48 samples including hands-on time of 30 minutes, which supports the use for high-throughput analyses in a routine laboratory.
We evaluated the feasibility of quantitative RT-kPCR for assessment of expression of the 3 breast cancerrelated biomarkers ESR1, PGR, and HER2 using the RNA isolated with our new method. The results from a series of 3 sections of each tumor showed that a highly reproducible and robust expression analysis of genes is possible over a large dynamic range of 3 to 4 logs in tissue samples from the same tumor. This reproducibility is a prerequisite for the use of the new method in clinical routine.
Comparing quantitative RT-kPCR with the standard method IHC for assessment of ESR1, PGR, and HER2 expression levels, we found an excellent concordance between both methods for ESR1 status with an agreement of 98%. Agreements of PGR and HER2 expression were slightly lower with values of 83% and 90%, respectively. This is in line with the results of other groups assessing receptor status in FFPE tissue using RT-kPCR. [24] [25] [26] [27] [28] Best agreement between PCR and IHC was always found for ESR1 (agreement 91% to 94%) whereas PGR and HER2 showed somewhat lower concordance in all published studies.
HER2 overexpression is currently being tested by a combination of IHC as a standard method and FISH or SISH to detect HER2 gene amplification. [29] [30] [31] Looking at concordance of HER2 status between IHC and RT-kPCR, we found an excellent negative agreement of 94%, whereas positive agreement was only 67%. In particular, the concordance was limited in samples with weak positive (score 2) or strong positive expression (score 3). A similar observation was made by Gong et al 32 in freshfrozen tissue using microarrays and by other groups in FFPE tissue using quantitative RT-PCR for HER2 testing in breast cancer specimens. 26, 28 Cases with Score 0 to 1 are similarly low in mRNA expression, whereas the group with Score 2+ to 3+ has similarly high mRNA levels. This suggests that further studies could define a clinically relevant cut-off for HER2 overexpression based on RT-kPCR. Also, concordance between genomic HER2 amplification and HER2 mRNA expression needs to be clarified in further studies.
For classification of ESR1, PGR, and HER2 status in RT-kPCR we used optimized cut-off values based on the bimodal distribution of expression values in column scatter plots. Furthermore, for each marker we defined an intermediate so called equivocal zone between the clearly positive and negative range. Similar to the situation for HER2, the equivocal zone might require the repeated assessment of biomarkers using additional diagnostic tests by other methods. The cut-off values used in this investigation are a basis for retrospective and prospective validations in clinical studies. As a first prospective validation, the PREDICT substudy of the neoadjuvant GeparQuinto study of the German Breast Group is currently conducted, to validate biomarkers for response to neoadjuvant chemotherapy in breast cancer.
In conclusion, our feasibility study shows that the novel method enables a reliable and high-throughput purification of RNA from the valuable archives of stored tumor tissues. The achieved agreement between IHC and RT-PCR, and the large dynamic range and reproducibility of the new method opens a new route in the field of personalized medicine. As mRNA-based receptor determination can predict tamoxifen response and clinical outcome, our new method may improve the predictive value of ESR1 status. 33, 34 As many upcoming biomarkers from gene expression studies are measured on the mRNA level, this method is a major technical improvement for implementation of reproducible and cost-efficient testing of such biomarkers in clinical routine and in research studies using archived FFPE material in molecular pathology diagnostic testing.
